Synergistic effect of paeonol and cisplatin on oesophageal cancer cell lines
Keywords: سیس پلاتین; Cisplatin; Drug interaction; Human oesophageal cell line; Paeonol
مقالات ISI سیس پلاتین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Electrochemotherapy in treatment of tumours
Keywords: سیس پلاتین; Electroporation; Electrochemotherapy; Bleomycin; Cisplatin; Cutaneous tumours
Cisplatin and dimethyl sulfoxide react to form an adducted compound with reduced cytotoxicity and neurotoxicity
Keywords: سیس پلاتین; Cisplatin; DMSO; Neurotoxicity; Cytotoxicity; Mass spectroscopy
Attenuating the toxicity of cisplatin by using selenosulfate with reduced risk of selenium toxicity as compared with selenite
Keywords: سیس پلاتین; Cisplatin; Selenosulfate; Selenite; Toxicity
Activity of novel Cdc25 inhibitors and preliminary evaluation of their potentiation of chemotherapeutic drugs in human breast cancer cells
Keywords: سیس پلاتین; Maleic anhydride derivatives; Cdc25 inhibitor; Cell cycle; Adriamycin; Cisplatin; Breast cancer
Cisplatin-mediated sensitivity to TRAIL-induced cell death in human granulosa tumor cells
Keywords: سیس پلاتین; Granulosa cell tumors; TRAIL; Cisplatin; p53; Apoptosis
Cisplatinâincorporated hyaluronic acid nanoparticles based on ionâcomplex formation
Keywords: سیس پلاتین; nanoparticles; cisplatin; hyaluronic acid; hyaluronidase; glioma cell;
Oxaliplatin activity in selected and unselected human ovarian and colorectal cancer cell lines
Keywords: سیس پلاتین; Cisplatin; Oxaliplatin; Drug response; Platinum accumulation; Platinum-DNA adducts; Transporters; p53; Cell cycle
Genistein protects the kidney from cisplatin-induced injury
Keywords: سیس پلاتین; cisplatin; genistein; inflammation; nuclear factor-κB; oxidative stress
Autophagy is cytoprotective during cisplatin injury of renal proximal tubular cells
Keywords: سیس پلاتین; autophagy; apoptosis; cisplatin; p53; Bcl-2; acute kidney injury
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma—A randomized phase II trial
Keywords: سیس پلاتین; Non-small cell lung carcinoma; Chemotherapy; Epirubicin; Cisplatin; Gemcitabine; Expression of excision repair cross-complementing group 1 (ERCC1); Topoisomerase IIα (TopoIIα)
Modeling therapy resistance in genetically engineered mouse cancer models
Keywords: سیس پلاتین; Genetically engineered mouse models; Breast cancer; Chemoresistance; Chemotherapy; P-glycoprotein; Cancer stem cells; Docetaxel; Doxorubicin; Cisplatin
Amifostine increases cure rate of cisplatin on ascites hepatoma 22 via selectively protecting renal thioredoxin reductase
Keywords: سیس پلاتین; Thioredoxin reductase; Cisplatin; Amifostine; Selectivity; Cure rate;
Characterization of cisplatin cytotoxicity delivered from PLGA-systems
Keywords: سیس پلاتین; Poly(d,l-lactic-co-glycolic acid) (PLGA); Microparticles; Nanoparticles; Cisplatin; Drug release; Cytotoxicity; Apoptosis
Defining targets of modulation of human tumor cell response to cisplatin
Keywords: سیس پلاتین; Cisplatin; Human tumor cells; Resistance; Modulation; Stress response
Expression of survivin and p16INK4a/Cdk6/pRB proteins and induction of apoptosis in response to radiation and cisplatin in meningioma cells
Keywords: سیس پلاتین; Apoptosis; Cisplatin; Meningiomas; pRB pathway; Survivin; γ-Rays;
Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway
Keywords: سیس پلاتین; Cisplatin; Nephrotoxicity; In vivo; Rat proximal tubular cell cultures; Human proximal tubular cell cultures
Selective iNOS inhibition reduces renal damage induced by cisplatin
Keywords: سیس پلاتین; Cisplatin; 1400W; Inducible nitric oxide synthase (iNOS); Nitric oxide (NO)
Interaction between celecoxib and docetaxel or cisplatin in human cell lines of ovarian cancer and colon cancer is independent of COX-2 expression levels
Keywords: سیس پلاتین; Cyclooxygenase; Combination index; Cisplatin; Docetaxel; Celecoxib
Efficacy and side effects of cisplatin- and carboplatin-based doublet chemotherapeutic regimens versus non-platinum-based doublet chemotherapeutic regimens as first line treatment of metastatic non-small cell lung carcinoma: A systematic review of randomi
Keywords: سیس پلاتین; Non-small cell lung carcinoma; Chemotherapy; Cisplatin; Carboplatin; Platinum; Meta-analysis; Systematic review
Deletion of exon 8 increases cisplatin-induced E-cadherin cleavage
Keywords: سیس پلاتین; AEC; anti-E-cadherin antibody; Akt/PKB; Akt/protein kinase B; cl; cleaved; CTL; control; DAPI; 4,6-diamidino-2-phenylindole; DMSO; dimethyl sulfoxide; del 8 E-cadherin, d8; E-cadherin with deletion of exon 8; fl; full length; MDA; untransfected, parental
Synthesis and cytotoxicity studies of methoxy benzyl substituted titanocenes
Keywords: سیس پلاتین; Anti-cancer drugs; Cisplatin; Titanocene; Hydridolithiation; Fulvene; RCC; LLC-PK;
Sensitivity of human prostate cancer cells to chemotherapeutic drugs depends on EndoG expression regulated by promoter methylation
Keywords: سیس پلاتین; Endonuclease G; DNA methylation; Prostate cancer; Cell death; Cisplatin
Effect of tumor suppressor gene PTEN on the resistance to cisplatin in human ovarian cancer cell lines and related mechanisms
Keywords: سیس پلاتین; PTEN; AKT; Ovarian cancer; Cisplatin; Multidrug resistance
Improved synthesis of unique estradiol-linked platinum(II) complexes showing potent cytocidal activity and affinity for the estrogen receptor alpha and beta
Keywords: سیس پلاتین; 17β-Estradiol-linked platinum(II) complex; Breast cancer; Estrogen receptor; Cisplatin; Biological activity
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
Keywords: سیس پلاتین; cisplatin; nephrotoxicity; renoprotection; apoptosis; inflammation
Enhanced DNA-PK-mediated RPA2 hyperphosphorylation in DNA polymerase η-deficient human cells treated with cisplatin and oxaliplatin
Keywords: سیس پلاتین; ICL; interstrand crosslink; ATM; ataxia telangiectasia mutated; ATR; ATM and Rad3-related; ATRIP; ATR interacting protein; PIKK; PI-3 kinase-related protein kinase; DNA-PK; DNA-dependent protein kinase; Polη; DNA polymerase η; RPA; replication protein A
The strand separation and nuclease activities associated with YB-1 are dispensable for cisplatin resistance but overexpression of YB-1 in MCF7 and MDA-MB-231 breast tumor cells generates several chemoresistance signatures
Keywords: سیس پلاتین; YB-1; Cisplatin; Chemoresistance; Microarray; Nuclease; Splicing
In vivo inhibition of E. coli growth by a Ru(II)/Pt(II) supramolecule [(tpy)RuCl(dpp)PtCl2](PF6)
Keywords: سیس پلاتین; Cisplatin; Anti-cancer agents; In vivo activity; Mixed metal supramolecular complexes; Anti-bacterial activity
Ototoxicity
Keywords: سیس پلاتین; apoptosis; cell death; outer hair cells; cisplatin; aminoglycosides
Inté^et du dosage du platine en cancérologie clinique
Keywords: سیس پلاتین; Platine; cisplatine; oxaliplatine; carboplatine; spectrométrie d'absorption atomique; Platinum; cisplatin; oxaliplatin; carboplatin; atomic absorption spectrometry;
Use of cisplatin without desensitization after carboplatin hypersensitivity reaction in epithelial ovarian and primary peritoneal cancer
Keywords: سیس پلاتین; carboplatin; cisplatin; hypersensitivity; ovarian cancer;
A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer
Keywords: سیس پلاتین; Cervix cancer; Cisplatin; Carboplatin; Paclitaxel; Recurrent; Advanced
A pilot study of cisplatin, ifosfamide and mesna in the treatment of malignant mixed mesodermal tumors of the ovary
Keywords: سیس پلاتین; Chemotherapy; Cisplatin; Ifosfamide; Malignant mixed mesodermal tumor of ovary; Ovarian cancer
Phase II Study of Gemcitabine and Cisplatin in Patients with Previously Untreated Extensive Stage Small Cell Lung Cancer: Southwest Oncology Group Study 9718
Keywords: سیس پلاتین; Cisplatin; Gemcitabine; Small cell lung cancer; Lung cancer; Small cell; Chemotherapy
Chemotherapy induced reversible posterior leukoencephalopathy syndrome
Keywords: سیس پلاتین; Lung malignancy; Chemotherapy; Cisplatin; Gemcitabine; Encephalopathy; Seizures
Addition of topotecan to standard cisplatin/etoposide combination in patients with extended stage small cell lung carcinoma
Keywords: سیس پلاتین; SCLC; Extensive-stage; Topotecan; Etoposide; Cisplatin
Cisplatin-induced long-term dynorphin A-immunoreactivity in cell somata of rat area postrema neurons
Keywords: سیس پلاتین; Dynorphin; Cisplatin; Anorexia; Delayed emesis; Pica; Immunohistochemistry
Iodination of cisplatin adduct of Vitamin B12 [{B12}-CN-{cis-PtCl(NH3)2}]+
Keywords: سیس پلاتین; Vitamin B12; Cisplatin; Radiopharmacy; Iodination;
A phase I study of gemcitabine followed by cisplatin concurrent with whole pelvic radiation therapy in locally advanced cervical cancer: A Gynecologic Oncology Group study
Keywords: سیس پلاتین; Gemcitabine; Cisplatin; Cervical cancer
Effect of pre-treatment with St John's Wort on nephrotoxicity of cisplatin in rats
Keywords: سیس پلاتین; Cisplatin; St John's Wort; Nephrotoxicity; Multidrug resistance protein 2; Metallothionein
Phase II study of neoadjuvant chemotherapy with mitomycin-c, vincristine and cisplatin (MVC) in patients with stages IB2–IIB cervical carcinoma
Keywords: سیس پلاتین; Neoadjuvant chemotherapy; Mitomycin-C; Vincristine; Cisplatin; Bulky cervical cancer
Biweekly gemcitabine and cisplatin in platinum-resistant/refractory, paclitaxel-pretreated, ovarian and peritoneal carcinoma
Keywords: سیس پلاتین; Gemcitabine; Cisplatin; Chemotherapy; Refractory; Resistant; Ovarian cancer
Effect of cisplatin on brush border membrane enzymes and anti-oxidant system of rat intestine
Keywords: سیس پلاتین; Cisplatin; Brush border membrane; Anti-oxidant; Intestine; Oxidative stress;
Tissue distribution evaluation of stealth pH-sensitive liposomal cisplatin versus free cisplatin in Ehrlich tumor-bearing mice
Keywords: سیس پلاتین; Stealth pH-sensitive liposomes; Cisplatin; Tissue distribution;
Concurrent chemoradiation with daily low dose cisplatin for advanced stage head and neck carcinoma
Keywords: سیس پلاتین; Chemoradiation; Cisplatin; Radiotherapy; Head and neck cancer
Point mutation of K-ras gene in cisplatin-induced lung tumours in A/J mice
Keywords: سیس پلاتین; Second primary cancer; Cisplatin; K-ras mutation; A/J mouse
β4GalT-II increases cisplatin-induced apoptosis in HeLa cells depending on its Golgi localization
Keywords: سیس پلاتین; β4GalT-II; Apoptosis; Cisplatin; HeLa cells; Golgi localization
A naturally occurring genetic variant of human XRCC2 (R188H) confers increased resistance to cisplatin-induced DNA damage
Keywords: سیس پلاتین; DNA repair gene; Homologous recombination; Single nucleotide polymorphism; DT40; Cancer risk; Cisplatin; RAD51; XRCC2; XRCC3
Studies on the activity of three palladium(II) compounds of the form: Trans-PdL2Cl2 where L = 2-hydroxypyridine, 3-hydroxypyridine, and 4-hydroxypyridine
Keywords: سیس پلاتین; Cisplatin; Transplatin; Palladium; 3-Hydroxypyridine; Antitumour activity; MTT